BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26614790)

  • 1. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
    Icli A; Cure E; Cure MC; Uslu AU; Balta S; Mikhailidis DP; Ozturk C; Arslan S; Sakız D; Sahin M; Kucuk A
    Angiology; 2016 Sep; 67(8):749-55. PubMed ID: 26614790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
    Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
    Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-α, age of onset, and body fat.
    Elkamshoushi AM; Omar SS; El Abd AM; Hassan SZ; Sultan EA; Abd Elkawy E
    Int J Dermatol; 2019 Apr; 58(4):456-464. PubMed ID: 30471086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.
    Sabry HH; Sabry JH; Daifalla AEH; Akl EM; Hamed AM; Torky AAA
    Vasc Health Risk Manag; 2018; 14():145-152. PubMed ID: 30022835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.
    Lv Y; Zhang Y; Shi W; Liu J; Li Y; Zhou Z; He Q; Wei S; Liu J; Quan J
    Am J Med Sci; 2017 May; 353(5):433-438. PubMed ID: 28502328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.
    Ozalper V; Kara M; Tanoglu A; Cetındaglı I; Ozturker C; Hancerlı Y; Hıra S; Kara K; Beyazıt Y; Yazgan Y
    Clin Rheumatol; 2017 Sep; 36(9):2071-2077. PubMed ID: 28074304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
    Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
    Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.
    Rodríguez M; Guardiola M; Oliva I; Carles Vallvé J; Ferré R; Masana L; Parra S; Ribalta J; Castro A
    Int J Rheum Dis; 2019 Mar; 22(3):480-487. PubMed ID: 30450745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study.
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Kurtoglu E; Demir M; Celik T; Turker T; Iyisoy A
    Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
    Park YJ; Shin YJ; Kim WU; Cho CS
    Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel marker relationship between carotid intima media thickness and disease activity score-28 in patients with rheumatoid arthritis: Human endothelial cell-specific molecule-1.
    Tuzcu G; Uslu AU; Tuzcu A; Aydoğan Baykara R; Omma A; Küçük A
    Turk J Med Sci; 2019 Dec; 49(6):1599-1605. PubMed ID: 31655533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density.
    Rodríguez-Carrio J; Martínez-Zapico A; Cabezas-Rodríguez I; Benavente L; Pérez-Álvarez ÁI; López P; Cannata-Andía JB; Naves-Díaz M; Suárez A
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):135-143. PubMed ID: 30559042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus.
    Jung JY; Koh BR; Bae CB; Kim HA; Suh CH
    Lupus; 2014 Dec; 23(14):1517-22. PubMed ID: 25059488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid intima-media thickness and plaque as surrogate biomarkers of atherosclerosis among consecutive women with systemic lupus erythematosus.
    Belibou C; Ancuţa C; Ancuţa E; Filoş C; Chirieac R
    Rom J Morphol Embryol; 2012; 53(1):29-34. PubMed ID: 22395496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study.
    Jung JY; Kim HA; Lee HY; Suh CH
    Int J Rheum Dis; 2019 Aug; 22(8):1410-1418. PubMed ID: 31050219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.
    Yilmaz MI; Siriopol D; Saglam M; Kurt YG; Unal HU; Eyileten T; Gok M; Cetinkaya H; Oguz Y; Sari S; Vural A; Mititiuc I; Covic A; Kanbay M
    Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
    Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus.
    Ahmad HM; Sarhan EM; Komber U
    Rheumatol Int; 2014 May; 34(5):617-23. PubMed ID: 24101173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.